Immunomodulator comedication promotes the reversal of anti-drug antibody-mediated loss of response to anti-TNF therapy in inflammatory bowel disease.
Johannes StallhoferJan GuseMiriam KesselmeierPhilip Christian GrunertKathleen LangeRobert StalmannVerena EckardtAndreas StallmachPublished in: International journal of colorectal disease (2023)
Immunogenic LOR to infliximab or adalimumab in IBD can be successfully reversed using immunomodulator comedication.